Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.25 and traded as low as $0.2240. Northwest Biotherapeutics shares last traded at $0.2484, with a volume of 6,334,729 shares changing hands.
Northwest Biotherapeutics Stock Up 1.8%
The company has a market capitalization of $382.71 million, a P/E ratio of -4.14 and a beta of -0.56. The business has a fifty day moving average price of $0.24 and a 200 day moving average price of $0.25.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last released its quarterly earnings results on Friday, November 14th. The biotechnology company reported ($18.22) earnings per share for the quarter. The business had revenue of $0.20 million during the quarter.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
See Also
- Five stocks we like better than Northwest Biotherapeutics
- Investing in Construction Stocks
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- Why Invest in High-Yield Dividend Stocks?
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
- 3 Best Fintech Stocks for a Portfolio Boost
- Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
